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Summary 
Release of a thin topical application of a drug is modeled by transient diffusion between the application, the underlying stratum 
corneum, and a receptor. Cases treated include sudden contact of the application with drug-free stratum corneum, and initially 
equilibrated application and stratum comeum. The method of solution is the numerical inversion of the analytic Laplace Transform 
of the exact solution, which has speed, accuracy and convenience advantages over classical analytical or numerical methods for 
coupled linear partial differential equations. The algorithm for long-time solutions in the time domain is also found, although this has 
no computational advantage over the direct numerical transform inversion. 
Introduction 
In studies involving the transdermal delivery of 
drugs across the skin, permeation experiments are 
usually performed under steady-state conditions, 
and the results are interpreted through the use of 
steady-state models. However, in the clinical set- 
ting, drug delivery occurs from applications which 
are only 20-50 pm in thickness (Flynn et al., 
1985). Thus, even when a drug is formulated at 
high percentage composition, only a minute mass 
of drug is available for diffusion per unit area of 
the application. Under this condition, permeation 
is almost certainly a non-steady process. Two con- 
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certed, complex sets of events control the delivery 
of drugs across the skin in this situation. The 
initial kinetic factors of consequence are those 
that control movement of mass within the dosage 
form itself. Of at least equal importance are the 
factors that control mass transfer across the skin. 
A model describing drug delivery through the skin 
from a finite topical application should properly 
account for all these factors. Such a comprehen- 
sive model would aid in the design of in vitro 
experiments by clearly elucidating the relative im- 
portance of the various rate-influencing processes. 
In addition, the model would expedite the design 
of topical dosage forms, as it would enable formu- 
lators to predict the rate of drug delivery from a 
particular topical formulation. 
Equations describing the diffusion of a drug 
through the skin from a thin topical application in 
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which the drug is in solution were derived by Guy 
and Hadgraft (1980). That model is based on the 
assumption that the skin is initially devoid of 
drug. Although totally reasonable theoretically, 
this initial condition makes the model difficult to 
verify experimentally. This is so because it takes 
an appreciable time to spread the topical dosage 
form, for example, a gel, onto the membrane of 
study, place it in the diffusion chamber with the 
applied film of formulation intact and then set the 
experiment into motion. Moreover, air bubbles, 
which are usually present, must then be teased out 
of the cell before the experiment can proceed. 
Consequently significant time elapses between the 
application of the formulation to the membrane 
and the start of an experiment. During this time 
the drug diffuses into the membrane, leading to 
uncertainty as to how closely the boundary condi- 
tions of the model are experimentally met. This 
concern is particularly acute for cases in which the 
drug has a high membrane/application partition 
coefficient and/or is present in an ultra-thin ap- 
plication thickness and/or diffuses readily through 
the membrane, as all of these factors contribute to 
a large percentage of the contents of the applica- 
tion being delivered into the membrane in a short 
period. The time involved in preparing the mem- 
brane would not be expected to present problems 
in typical experiments involving intact skin where 
diffusional times through the statum corneum are 
long compared to preparation times. However, 
problems are likely to be encountered when one 
attempts to study permeation from thin applica- 
tions through damaged skin or synthetic mem- 
branes. 
This paper describes the derivation and solu- 
tion of an equation that generalizes the Guy and 
Hadgraft model, which allows alternative initial 
conditions with respect to drug concentration in 
the application and the membrane to be consid- 
ered. Equations for two initial conditions are 
specifically presented; one for the previously 
studied case in which the membrane is initially 
devoid of drug and another for the new case in 
which the drug is allowed to equilibrate between 
the application and the membrane prior to the 
start of an experiment. The latter is a useful initial 
condition with respect to in vitro experiments. 
The solutions to the model are presented in the 
Laplace domain and only numerical inversion is 
required, rather than analytical or numerical solu- 
tion of coupled partial differential equations. 
Derivation 
Assume that the diffusion of a drug from a 
topical dosage form takes place in accordance 
with the scheme depicted in Fig. 1. In this di- 
agram, C8 and C,, (not assumed to be uniform) 
are the drug’s concentrations in the vehicle appli- 
cation and stratum corneum, D, and Ds, are the 
drug’s diffusion coefficient in the vehicle applica- 
tion and the drug’s effective diffusion coefficient 
in the stratum corneum, and h, and h,, are the 
thicknesses of the application and stratum corne- 
urn. respectively. The total thickness of the com- 
posite, h is defined as h, + h,,. K is the partition 
coefficient at the membrane/application inter- 
face, and is defined as C,,/C,. It is assumed that a 
sink condition (C = 0) exists at the membraneere- 
ceptor interface at all times. An equation is sought 
which describes the mass of drug being released 
into the sink as a function of time. 
The equations that govern diffusion in the ap- 
plication phase and the stratum corneum phase 
are: 




i 1 =ac,, ax2 at . (2) 
The generalized initial conditions for the problem 
are: 
c, = C”” h>x>h,, t=O (1.C.l) 
G = Go h,,>x>O t=O (I.C.2) 
The boundary conditions (for all time) are: 
ac, 
ax 
-0 x=h (B.C.l) 
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Fig. 1. Schematic representation of a topical application as it 




D”(z) =I$.(!$$ x=h,, (B.C.4) 
These equations are conveniently simplified by 
the method of Laplace Transforms. Guy and 
Hadgraft (1980) show the manipulations for the 
case CScO = 0. The same procedures, with CScO # 0, 
are shown by Addicks (1988), and yield: 
$ = [~/{(C,,h, + Clcdrcb3’*}] 
cc 
(C,,K- CS,,) sinh 
{K( +cosh~h;cosh~h,, 
+sinhEhV.sinhEhSc)lil)] .._ + . . . 





where M* and M, are the mass transferred up to 
time t and the initial drug loading, respectively, 
and s is the Laplace Transform variable. 
For reasons previously mentioned it is useful to 
have an expression for the situation in which the 
drug is initially in equilibrium with both the mem- 
brane and application. In this case, the model 
assumes that prior to the start of an experiment 
the application is placed onto the membrane until 
a state of equilibrium is reached. This is not a 
realistic situation for drug delivery clinically but it 
does describe the simplest case for preparing a 
membrane for mass transport study using in vitro 
diffusion cell methodology. For this case the fol- 
lowing initial condition applies: 
Csco = K. C,, h > x > 0 (I.C.3) 
This initial condition in Eqn. 3 gives: 
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~cosh~~h,,/ + sinh/$h, 
. sinh (4) 
For the case in which the membrane is initially 
free of drug, the following initial condition ap- 
plies: 
c,,,=o h,,>x>O, t=O 
This initial condition in Eqn. 3 gives: 
*sinh 




nomenclature) to that found by Guy and Hadgraft 
(1980). 
Discussion 
In order to be used, Eqns. 4 and 5 must be 
inverted from functions of s to functions of t. 
Tables containing functions and their Laplace 
transformations have been compiled and are typi- 
cally used for this purpose. However, Eqns. 4 and 
5 are not found in the published literature, and 
thus inversion must be performed via numerical 
methods. Because of this, Guy and Hadgraft (1980) 
attempted only to find long-term and short-term 
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Fig. 2. Relative mass versus time profiles as predicted by Eyns. 
4 and 5. Parameter values used in the simulations are found in 
the text. 
solutions. Numerical inversion is today, however, 
easily accomplished with the use of the fast Four- 
ier transform, which is available in numerous 
computer libraries. The validity of this method 
was demonstrated in a recent paper where the 
analytical solution and an orthogonal solution to 
an equation describing a fixed-bed adsorber were 
compared to the solution obtained through the use 
of the fast Fourier transforms (Chen and Hsu, 
1987). The 3 solutions were identical. and the fast 
Fourier transform method was found to be two 
orders of magnitude faster than the orthogonal 
collocation method. This method is a new and 
extremely powerful tool for the solution of any 
diffusional problem encountered in biological and 
pharmaceutical systems. 
Fig. 2 shows the solutions of Eqns. 4 and 5 for 
the case in which the drug’s membrane diffusivity 
is 2.0 X IO-’ cm*/s, the diffusivity in the vehicle is 
7.0 X 10Ph cm2/s, the drug’s membrane/vehicle 
partition coefficient is 0.5, and the thicknesses of 
the membrane and vehicle are 250 pm and 75 pm, 
respectively. These parameter values are similar to 
those that might be encountered in the case of 
drug diffusion from a topical dosage form through 
a silicone rubber membrane, a membrane used as 
a model membrane in some of our work. As 
expected, the situation in which the drug is ini- 
tially in equilibrium between membrane and 
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vehicle (Eqn. 4) is associated with a much faster 
initial rate of drug delivery than when the mem- 
brane is initially free of drug (Eqn. 5). This early 
unloading of drug has been termed a “burst ef- 
fect” in some literature. A lag time associated with 
the establishment of the concentration gradient 
across the membrane characterizes the situation in 
which the membrane is initially devoid of drug. 
Guy and Hadgraft (1980) found the long-time 
solution in the time domain, for Eqn. 5, by finding 
the small s algebraic limit. This procedure is not 
entirely correct. The long-time solution is obtained 
by finding the dominant (small) pole of the trans- 
fer function, as described by, e.g. Churchill (1944). 
To illustrate for just Eqn. 5: the poles of Eqn. 5 
are only real and non-positive, and lie as s = 0 and 
the roots of: 
tanEIz, X tanEh,, = KE (6) 
-I 
0 100 200 300 400 500 600 
Time (Set) 
Fig. 4. Relative mass versus time profiles as predicted by the 
exact (Eqn. 5) and long-time approximate solutions for diffu- 
sion through abraded skin (case 2 as described in text). The 
simulations are virtually coincident. 
Case 1 2 
Two comparisons of the long-time and exact solu- 
tions are shown in Figs. 3 and 4. The parameters 
correspond to the cases considered by Guy and 
Hadgraft (1980) and are: 
Figure 3 4 
D,, (cm2/s) 1 x lo--lo 1 x 1o-6 
D” 1 x 1o-6 1 x 1o-6 
K 0.5 1.0 
A,, (pm) 10 150 
h, 20 20 
--s (h-l) 0.0830 30.7 
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Fig. 3. Relative mass versus time profiles as predicted by the 
exact (Eqn. 5) and long-time approximate solutions for diffu- 
sion through normal skin (case 1 as described in text). The 
simulations are virtually coincident. 
Case 1 corresponds to drug diffusion from a thin 
topical application into normal skin, and Case 2 
to diffusion into abraded skin. The long-time solu- 
tions are essentially identical to the exact solution 
except (of course) at short times. The long-time 
expressions are easily found by the partial fraction 
expansion of Eqn. 5. Retaining only the first ex- 
ponential term yields, for Case 1: 
M* = 1 - 1.038 exp( -0.0830 t) 
M* 




which are plotted in Figs. 3 and 4 for the region of 
time for which they are positive. 
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A more complete partial fraction expansion is 
readily done by finding more (larger) roots of 
Eqn. 5, and using the methods of partial fraction 
expansions to determine the coefficients. This is 
readily implemented with a computer, but has 
hardly any advantage over the numerical inversion 
of the complete Laplace Transform unless an alge- 
braic expression in the time domain is desired. 
In summary, a general solution in terms of 
Laplace transforms has been obtained for the 
problem of drug diffusion from a thin topical 
application through a resistant membrane. Solu- 
tions have been presented for the case in which 
the membrane is initially free of drug as well as 
for the case in which the drug is initially in 
equilibrium with respect to the vehicle and mem- 
brane, a situation which allows one to more easily 
study transport from thin topical applications 
through highly permeable membranes. These exact 
solutions have been numerically inverted, and the 
former case has been compared to long-time ap- 
proximate solutions. However, the approximate 
solution method has no advantage over the direct 
numerical inversion of the Laplace Transform of 
the solution, in either time or convenience. 
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